Amarantus Bioscience Holdings Inc (AMBS)

[Solantey]

Stem Cells As A Solution:

http://www.technologyreview.com/news/426037/new-method-for-making-neurons-could-lead-to-parkinsons-treatment/

Note the pre-clinical testing required. It's substantially more than a few rats.

MANF "could" lead to a drug in 10 years and a billion dollars having been invested.

http://www.pdpipeline.org/2011/Eithics/navagating/regulatory.htm

Current value for a buyout "if" a big pharma company wanted to invest a billion dollars is in the .33 range. Not a penny more.

The current share price is reasonable until the next dilution occurs.

All imho.